GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals in China
GSK in agreement to acquire MeiRui for approx $70 million. 90% of share capital is to be acquired from Pagoda, remaining 10 from Allergon.
Read the full article15y agoen
You might also wanna read
OpenAI No. 2 Executive Fidji Simo Steps Down from Full-Time Role to Focus on Health Recovery
Variety·6h ago
Why ambulance rides in the US are so expensive: The broken economics of emergency medical transport
davidoks.blog·8h agoModerna's mResvia gets shot in the arm from EU contract
pharmaphorum·8h ago
Australia news live: Hanson defends UK ‘fact-finding’ trip; Qantas tops airline punctuality table
The Guardian·8h ago
STAT+: FDA finalists under review
STAT·15h ago
STAT+: Prime wins Beam arbitration, clearing path to clinic
STAT·16h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.